Anita Mahajan, MD, a radiation oncologist at the University of Texas MD Anderson Cancer Center, Houston, moderated the press conference where these findings were discussed.
“Use of radiation for atypical meningiomas has been controversial. It has been difficult to put a study together, because we thought we had a good handle on how to manage these tumors. But we managed to pull this off in a cooperative group setting, and now a randomized phase III trial is being proposed,” Dr. Mahajan remarked.
“One of the most important things to emphasize is that management of brain tumors is multidisciplinary and involves collaboration between surgeons and radiation oncologists. In general, modern cancer care requires a multidisciplinary approach. You need your partners,” she stated. ■
Disclosure: Dr. Mahajan reported no potential conflicts of interest.
Management of the vast majority of meningiomas is straightforward, but treatment of atypical meningiomas has been controversial. Should radiation be part of therapy or not has been the question. The first analysis of Radiation Therapy Oncology Group (RTOG) 0539 suggested that patients will have...